Italian study to evaluate the efficacy of retinoic acid and cabergoline therapy in combination in Cushing's disease. Italian study to evaluate the efficacy of retinoic acid and cabergoline therapy in combination in Cu ...
Medical combination therapy with retinoic acid and cabergoline in ACTH-secreting pituitary adenoma: a prospective and randomized study. - CRACCA Medical combination therapy with retinoic acid and cabergoline in ACTH-secreting pituitary adenoma: ...
Cushing's disease in patients in whom pituitary surgery has not been curative or in situations where it is contraindicated or refused by patient. MedDRA version: 20.0;Level: LLT;Classification code 10011651;Term: Cushing's disease;System Organ Class: 100000004860;Therapeutic area: Diseases [C] - Hormonal diseases [C19] Cushing's disease in patients in whom pituitary surgery has not been curative or in situations where ...
Trade Name: Dostinex Product Name: Cabergolina Product Code: [G02CB03] INN or Proposed INN: CABERGOLINA Other descriptive name: NON COMMERCIAL Trade Name: VESANOID Product Name: Tretinoina Product Code: [L01XX14] INN or Proposed INN: TRETINOINA Other descriptive name: NON COMMERCIAL Trade Name: Dostinex Product Name: Cabergolina Product Code: [G02CB03] INN or Proposed INN: CABERGOLINA ...
Dipartimento di Medicina-DIMED, università di Padova